INS and chronic kidney disease: IR may participate in the occurrence and development of CKD through such mechanisms as a hyperinsulinemic reaction (14), induction of oxidative stress (15), activation of a sympathetic renin-angiotensin-aldosterone system (16), activation of inflammatory factors (17), and inhibition of insulin signaling pathway (18).